Response letter: “Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules”

Detalles Bibliográficos
Autores principales: Costantini, Marco, Callegaro, Andrea, Beran, Jiří, Berlaimont, Valérie, Galgani, Ilaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560907/
https://www.ncbi.nlm.nih.gov/pubmed/32810427
http://dx.doi.org/10.1080/21645515.2020.1798713
_version_ 1783595177451978752
author Costantini, Marco
Callegaro, Andrea
Beran, Jiří
Berlaimont, Valérie
Galgani, Ilaria
author_facet Costantini, Marco
Callegaro, Andrea
Beran, Jiří
Berlaimont, Valérie
Galgani, Ilaria
author_sort Costantini, Marco
collection PubMed
description
format Online
Article
Text
id pubmed-7560907
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-75609072020-10-26 Response letter: “Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules” Costantini, Marco Callegaro, Andrea Beran, Jiří Berlaimont, Valérie Galgani, Ilaria Hum Vaccin Immunother Letter Taylor & Francis 2020-08-18 /pmc/articles/PMC7560907/ /pubmed/32810427 http://dx.doi.org/10.1080/21645515.2020.1798713 Text en © 2020 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter
Costantini, Marco
Callegaro, Andrea
Beran, Jiří
Berlaimont, Valérie
Galgani, Ilaria
Response letter: “Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules”
title Response letter: “Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules”
title_full Response letter: “Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules”
title_fullStr Response letter: “Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules”
title_full_unstemmed Response letter: “Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules”
title_short Response letter: “Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules”
title_sort response letter: “predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules”
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560907/
https://www.ncbi.nlm.nih.gov/pubmed/32810427
http://dx.doi.org/10.1080/21645515.2020.1798713
work_keys_str_mv AT costantinimarco responseletterpredictedlongtermantibodypersistenceforatickborneencephalitisvaccineresultsfromamodelingstudybeyond10yearsafteraboosterdosefollowingdifferentprimaryvaccinationschedules
AT callegaroandrea responseletterpredictedlongtermantibodypersistenceforatickborneencephalitisvaccineresultsfromamodelingstudybeyond10yearsafteraboosterdosefollowingdifferentprimaryvaccinationschedules
AT beranjiri responseletterpredictedlongtermantibodypersistenceforatickborneencephalitisvaccineresultsfromamodelingstudybeyond10yearsafteraboosterdosefollowingdifferentprimaryvaccinationschedules
AT berlaimontvalerie responseletterpredictedlongtermantibodypersistenceforatickborneencephalitisvaccineresultsfromamodelingstudybeyond10yearsafteraboosterdosefollowingdifferentprimaryvaccinationschedules
AT galganiilaria responseletterpredictedlongtermantibodypersistenceforatickborneencephalitisvaccineresultsfromamodelingstudybeyond10yearsafteraboosterdosefollowingdifferentprimaryvaccinationschedules

Ejemplares similares